
|Articles|September 14, 2015
- Squamous NSCLC
- Volume 1
- Issue 1
Evolving Paradigms in Squamous NSCLC: Conclusion
Author(s)Staff Writer
Squamous cell lung cancer represents a distinct molecular pathologic NSCLC with unmet therapeutic needs, especially after failure of first-line platinum-based doublet chemotherapy.
This article is Part III of a series. View parts I and II:Evolving Paradigms in Squamous NSCLC> >
Articles in this issue
about 10 years ago
Cancer Immunotherapy: Evolving Treatment Options in Squamous NSCLCabout 10 years ago
Evolving Paradigms in Squamous NSCLC: Referencesabout 10 years ago
Evolving Paradigms in Squamous NSCLC: Introduction



































